Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Atonarp

Explore full profile

A pioneer in developing technology for real-time chemical composition analysis

Tokyo, JapanFounded 2010Health Tech & Medtech
Valuation $100–250M Last recorded · 2026
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Atonarp and the history behind them.

About Atonarp

Atonarp is a technology startup that operates at the intersection of digital technology and molecular insights. It primarily serves clients in the life science research, semiconductor, and industrial process control sectors. The company's core offering is its digital molecular profiling technology, which is used to improve efficiency and reduce waste in various manufacturing processes, including those in the semiconductor, pharmaceutical, and life sciences industries.

Atonarp's technology is based on mass spectrometry and multi-laser optical spectrometry platforms. Mass spectrometry is a technique used to identify the amount and type of chemicals present in a sample by measuring the mass-to-charge ratio and abundance of gas-phase ions. In simpler terms, it's a way of figuring out what something is made of and how much of each thing is present. Atonarp's platforms use this technology, along with advanced analytics, to provide real-time, quantitative, and actionable results.

In addition to industrial process control, Atonarp also offers in vitro diagnostic tests for the life science research sector. These tests are chemistry-free and quantitative, meaning they can provide precise measurements without the need for chemical reactions. This allows for real-time disease diagnosis and monitoring, which can lead to improved patient outcomes and satisfaction, all at a lower cost.

Atonarp's business model is likely based on selling its technology and services to its clients in the aforementioned sectors. By helping these clients improve their manufacturing processes and research capabilities, Atonarp can generate revenue while also contributing to advancements in these industries.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2010
Headquarters
Tokyo, Japan
Employees
31
Open positions
None listed
Dealroom signal
69.9/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Analytics, Drug Development, Remote Monitoring, Chemistry, Health Diagnostics, Tech for Biotech and Pharma, Semiconductor Engineering Tools, Semiconductor Engineering Equipment
Technology
Deep Tech
Business model
Manufacturing, SaaS
Client focus
b2b

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing May 2021 $50M $200M Furukawa Electric · Banner Industries · Japan Post Investment · Boscolo Intervest —
SERIES COther financing Aug 2019 $33M $132M Post Investment Group · SBI Investment ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Atonarp website traffic

Latest recorded traffic for Atonarp is 1.8K monthly website visits, down 50% over the last three months. Atonarp's team declined 6.1% over the past year.

Latest monthly visits1.8K 3-month web change-50% 1-year team growth-6.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later9 investors entered at this stage

  • Nec
  • INCJ
  • Post Investment Group
  • SBI Investment
  • Furukawa Electric
  • Banner Industries
  • Japan Post Investment
  • Boscolo Intervest
  • ATI Korea
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇮🇳 India40.9%
🇯🇵 Japan27.3%
🇺🇸 United States27.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Atonarp on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Atonarp’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.